Verified Service Provider in Equatorial Guinea
Genomics Core Facilities in Equatorial Guinea
Engineering Excellence & Technical Support
Genomics Core Facilities solutions for Research & Discovery (R&D). High-standard technical execution following OEM protocols and local regulatory frameworks.
Next-Generation Sequencing (NGS) Capabilities
Empowering Equatorial Guinea's researchers with cutting-edge Illumina NovaSeq and Nanopore sequencing platforms for high-throughput whole-genome, exome, and transcriptome sequencing, accelerating discovery in infectious diseases and biodiversity.
Advanced Bioinformatics & Data Analysis
Providing expert bioinformatics support and robust computational infrastructure to analyze complex genomic datasets, enabling robust interpretation of findings and fostering local data science expertise for health and agricultural applications.
Genomic Applications for Agriculture & Conservation
Leveraging genomic tools to support sustainable agriculture through crop improvement and pest management, and contributing to vital conservation efforts by characterizing unique flora and fauna of Equatorial Guinea's rich ecosystems.
What Is Genomics Core Facilities In Equatorial Guinea?
Genomics Core Facilities (GCFs) in Equatorial Guinea, as in other global research ecosystems, are specialized service units that provide access to advanced genomic technologies, methodologies, and expertise. These facilities are designed to support research and diagnostic applications by offering state-of-the-art equipment and trained personnel, enabling the generation and analysis of genomic data. The primary objective of a GCF is to democratize access to complex genomic platforms, thereby accelerating scientific discovery, facilitating clinical diagnostics, and advancing public health initiatives within the country.
| Who Needs Genomics Core Facilities? | Typical Use Cases | |||||
|---|---|---|---|---|---|---|
| Academic Researchers: Investigators in universities and research institutions pursuing fundamental biological questions across various disciplines (e.g., molecular biology, genetics, ecology, evolutionary biology). | Clinical Diagnostics: Hospitals and diagnostic laboratories for genetic disease screening, pathogen identification and characterization (e.g., infectious disease surveillance), and pharmacogenomics. | Public Health Agencies: Government health organizations involved in disease surveillance, outbreak investigations, vaccine development research, and understanding the genetic basis of endemic diseases. | Biotechnology and Pharmaceutical Companies (if present): Companies engaged in drug discovery, development, and precision medicine, requiring high-throughput genomic data for target identification, biomarker discovery, and clinical trial support. | Agricultural and Environmental Sectors: Researchers and organizations focused on crop improvement, livestock breeding, biodiversity assessment, and environmental monitoring. | Students and Trainees: Individuals undergoing training in genomics and bioinformatics, gaining hands-on experience with cutting-edge technologies. | |
| Whole Genome/Exome Sequencing: Identifying genetic variations associated with diseases, traits, or evolutionary history. Used in cancer genomics, rare disease diagnosis, and population genetics studies. | RNA Sequencing (RNA-Seq): Studying gene expression patterns to understand cellular function, identify disease biomarkers, and investigate developmental processes. Applications include transcriptomics in cancer, immunology, and neuroscience. | Metagenomics: Analyzing genetic material from environmental or host-associated microbial communities to understand microbial diversity, function, and interactions. Relevant for gut microbiome research, soil ecology, and infectious disease transmission. | Targeted Sequencing: Focusing on specific genes or genomic regions of interest for diagnostic purposes or to validate findings from broader sequencing studies. Used in inherited disorder testing and mutation profiling. | Genotyping and SNP Analysis: Determining genetic variants at specific locations in the genome, crucial for association studies, marker-assisted selection in agriculture, and ancestry analysis. | Long-Read Sequencing: Enabling the assembly of complex genomes, detection of structural variants, and characterization of repetitive regions. Useful for de novo genome assembly and epigenomic studies. | Pathogen Sequencing: Rapid identification, characterization, and tracking of infectious agents (bacteria, viruses) for outbreak control and understanding antimicrobial resistance. |
Key Aspects of Genomics Core Facilities
- Technological Access: Providing access to a suite of high-throughput sequencing platforms (e.g., Illumina, Oxford Nanopore), fragment analysis systems (e.g., Sanger sequencing, capillary electrophoresis), real-time PCR, and associated library preparation automation.
- Methodological Expertise: Offering comprehensive support in experimental design, sample preparation (DNA/RNA extraction, quality control), library construction, data generation, and basic bioinformatics analysis pipelines.
- Training and Consultation: Delivering workshops, training sessions, and one-on-one consultations to researchers and clinicians on best practices in genomics, experimental design, and data interpretation.
- Data Management and Storage: Implementing robust data management strategies and providing secure storage solutions for large genomic datasets.
- Quality Assurance: Adhering to strict quality control protocols throughout the workflow to ensure the reliability and reproducibility of generated data.
Who Needs Genomics Core Facilities In Equatorial Guinea?
Genomics core facilities are essential for advancing research and development in various sectors, even in a developing nation like Equatorial Guinea. They provide access to cutting-edge technologies and expertise that would otherwise be unavailable to individual research groups or institutions. This allows for a deeper understanding of biological systems, leading to potential breakthroughs in agriculture, medicine, and environmental conservation. By supporting local scientific endeavors, these facilities can contribute to the nation's self-sufficiency in scientific research and foster a more robust innovation ecosystem.
| Target Customer/Department | Specific Needs/Applications | Potential Impact |
|---|---|---|
| Universities (e.g., Universidad Nacional de Guinea Ecuatorial) | Basic research in biology, genetics of local flora and fauna, training of future scientists. | Enhanced research output, development of local scientific talent, contribution to global scientific knowledge. |
| Ministry of Agriculture and Forestry | Crop improvement (disease resistance, yield), livestock health and breeding, understanding local biodiversity. | Increased food security, improved agricultural productivity, sustainable resource management. |
| Ministry of Public Health | Disease surveillance (infectious diseases), diagnostic capabilities, understanding genetic predispositions to diseases, pharmacogenomics. | Improved public health outcomes, more effective disease control, personalized medicine initiatives. |
| Ministry of Environment and Sustainable Development | Biodiversity studies, conservation genetics, impact of environmental changes on ecosystems, bioprospecting. | Effective conservation strategies, sustainable use of natural resources, potential for new bioproducts. |
| National Institute for Medical Research (if established) | Translational research, clinical trials support, development of diagnostics and therapeutics for local health challenges. | Advancement of medical knowledge and treatments tailored to the Guinean population. |
| Veterinary Services | Animal disease diagnostics, breeding programs for livestock, understanding zoonotic diseases. | Improved animal health, enhanced livestock productivity, prevention of disease transmission to humans. |
| Emerging Biotechnology/Pharmaceutical Companies | Drug discovery and development, development of diagnostic tools, contract research services. | Stimulation of the local biotech industry, job creation, economic diversification. |
Target Customers and Departments for Genomics Core Facilities in Equatorial Guinea
- Academic and Research Institutions
- Government Agencies
- Healthcare Providers
- Agricultural Sector
- Conservation and Environmental Organizations
- Biotechnology and Pharmaceutical Companies (emerging)
Genomics Core Facilities Process In Equatorial Guinea
Genomics core facilities in Equatorial Guinea are crucial for advancing research and diagnostics. The process from inquiry to execution typically involves several distinct stages, ensuring efficient resource allocation and high-quality data generation. This workflow is essential for researchers, clinicians, and public health officials to access cutting-edge genomic services.
| Stage | Description | Key Activities | Responsible Parties | Timeline (Estimated) |
|---|---|---|---|---|
| Initial Inquiry and Consultation | The process begins with a researcher or clinician contacting the core facility to discuss their project needs. | Email or phone inquiry, scheduling a meeting, discussing experimental design, feasibility assessment, quoting services. | Researcher/Clinician, Core Facility Staff (Scientific Manager, Technical Staff) | 1-3 business days |
| Sample Submission and Preparation | Once the project is approved, samples are collected and submitted to the core facility for processing. | Sample collection (if applicable), sample receipt and tracking, DNA/RNA extraction, library preparation, quality assessment of nucleic acids. | Researcher/Clinician (sample collection), Core Facility Staff (extraction, library prep, QC) | 3-10 business days (depending on sample type and quantity) |
| Data Generation and Quality Control | The prepared libraries are sequenced using state-of-the-art equipment, followed by rigorous quality checks. | Sequencing (e.g., Illumina, Nanopore), raw data generation, initial data QC (e.g., read quality, base composition, adapter contamination). | Core Facility Staff (Sequencing Specialists, Bioinformaticians) | 2-14 business days (depending on sequencing platform and throughput) |
| Data Analysis and Interpretation | Raw sequencing data is processed and analyzed to extract meaningful biological insights. | Raw data processing (e.g., demultiplexing, trimming), alignment to reference genomes, variant calling, gene expression analysis, data visualization. | Core Facility Staff (Bioinformaticians) | 5-30 business days (highly variable based on project complexity and data volume) |
| Reporting and Deliverables | The analyzed results are compiled into comprehensive reports for the client. | Generating summary reports, providing raw and processed data files, presenting findings, discussing implications. | Core Facility Staff (Bioinformaticians, Scientific Manager) | 2-5 business days |
| Follow-up and Support | The core facility provides ongoing support and can assist with further analysis or future projects. | Answering follow-up questions, assisting with manuscript preparation, planning for future experiments, archiving data. | Core Facility Staff (All levels) | Ongoing |
Genomics Core Facility Workflow in Equatorial Guinea
- Initial Inquiry and Consultation
- Sample Submission and Preparation
- Data Generation and Quality Control
- Data Analysis and Interpretation
- Reporting and Deliverables
- Follow-up and Support
Genomics Core Facilities Cost In Equatorial Guinea
Assessing the cost of genomics core facilities in Equatorial Guinea presents a unique challenge due to the nascent stage of advanced molecular biology infrastructure in the country and the significant influence of imported technologies and expertise. Pricing is not standardized and will vary considerably based on the specific services, the institution offering them (which are likely to be governmental research institutions, universities, or international collaborative projects), the complexity of the genomic assays, and the need for specialized reagents and consumables, many of which will be imported. Therefore, cost ranges are estimations and subject to fluctuation. It's important to note that direct, publicly available pricing for "genomics core facilities" in Equatorial Guinea is scarce. The following discussion outlines the key factors influencing costs and provides estimated ranges in the local currency, the Central African CFA franc (XAF).
| Genomic Service (Estimated) | Estimated Cost Range (XAF) | Notes |
|---|---|---|
| DNA/RNA Extraction (per sample) | 15,000 - 50,000 | Depends on sample type and kit used. |
| Sanger Sequencing (per reaction) | 20,000 - 60,000 | Includes sequencing and basic analysis. Primers may be an additional cost. |
| PCR Amplification (per reaction) | 5,000 - 20,000 | Cost of reagents and consumables. Mastermix may be cheaper per reaction. |
| Library Preparation for NGS (per sample) | 50,000 - 200,000 | Highly dependent on the NGS platform and kit complexity. |
| Whole Genome Sequencing (WGS) - Low Coverage (per sample) | 500,000 - 1,500,000 | Excludes extensive bioinformatics. Cost heavily influenced by sequencing platform and reagent imports. |
| Whole Genome Sequencing (WGS) - High Coverage (per sample) | 1,500,000 - 5,000,000+ | Significant reagent and sequencing time costs. Bioinformatics can be an additional substantial cost. |
| Targeted Sequencing (e.g., Exome) (per sample) | 800,000 - 3,000,000 | Includes exome capture and sequencing. Bioinformatics separate. |
| RNA Sequencing (RNA-Seq) - Basic (per sample) | 700,000 - 2,500,000 | Includes library prep and sequencing. Bioinformatics separate. |
| Bioinformatics Analysis (Basic) (per project) | 200,000 - 1,000,000 | For routine variant calling or expression analysis. Complex analyses will be higher. |
| Bioinformatics Analysis (Advanced) (per project) | 1,000,000 - 5,000,000+ | For de novo assembly, population genetics, or complex functional genomics. Highly variable. |
Key Pricing Factors for Genomics Core Facilities in Equatorial Guinea
- {"title":"Type of Genomic Service","description":"Different services have vastly different reagent and labor costs. For example, simple PCR amplification is less expensive than whole-genome sequencing or complex transcriptomic analysis."}
- {"title":"Sequencing Technology and Depth","description":"The choice of sequencing platform (e.g., Illumina, Nanopore) and the desired sequencing depth (e.g., low-pass vs. high-depth sequencing) significantly impacts costs. Higher throughput and deeper sequencing translate to higher expenses."}
- {"title":"Sample Type and Preparation","description":"The source of the genetic material (e.g., blood, tissue, plant material, microbial culture) and the complexity of DNA/RNA extraction and library preparation can add to the cost."}
- {"title":"Reagent and Consumable Costs","description":"A substantial portion of the cost is driven by specialized reagents (enzymes, buffers, kits), sequencing kits, and consumables, which are almost exclusively imported, incurring import duties, shipping fees, and currency exchange rate fluctuations."}
- {"title":"Equipment and Maintenance","description":"The capital investment in high-throughput sequencers, PCR machines, centrifuges, and other essential laboratory equipment, along with ongoing maintenance contracts and calibration, contributes to the overhead."}
- {"title":"Personnel and Expertise","description":"The cost of highly skilled personnel (bioinformaticians, molecular biologists, laboratory technicians) is a significant factor. Often, specialized expertise may need to be sourced internationally, further increasing costs."}
- {"title":"Data Analysis and Bioinformatics","description":"The computational infrastructure and expertise required for processing, analyzing, and storing large genomic datasets are critical and can represent a substantial expense, especially for complex analyses."}
- {"title":"Institutional Overhead and Indirect Costs","description":"University or research institution overhead charges, administrative support, and facility usage fees will be incorporated into the pricing structure."}
- {"title":"Import Duties and Taxes","description":"Taxes and import duties on specialized equipment, reagents, and consumables will directly impact the final cost."}
- {"title":"Volume and Service Level Agreements","description":"Larger projects or long-term service agreements might negotiate discounted rates. Conversely, small, one-off projects may incur higher per-unit costs."}
Affordable Genomics Core Facilities Options
Affordable genomics core facilities are crucial for researchers with limited budgets. They offer access to cutting-edge technologies and expertise without the need for individual labs to invest in expensive equipment. Key strategies for cost savings and maximizing value revolve around understanding and leveraging service models, particularly 'value bundles' and adopting smart operational practices.
| Strategy | Description | Potential Savings |
|---|---|---|
| Value Bundles | Pre-packaged services at a discounted rate. | 10-30% savings on individual service costs. |
| Volume Discounts | Tiered pricing based on sample/service quantity. | Up to 50% reduction for high-volume commitments. |
| Shared Projects | Collaborating with other labs for collective submissions. | Access to volume discounts and reduced per-sample cost. |
| Optimized Sample Prep | Ensuring high-quality input to avoid re-runs. | Reduces reagent, sequencing, and personnel costs. |
| In-House Cost Comparison | Accurate assessment of internal versus external service costs. | Avoids overspending on underutilized equipment or inefficient processes. |
| Bioinformatics Bundles | Purchasing analysis as a package deal. | Significant savings compared to individual bioinformatics consultations or staff costs. |
| Strategic Service Selection | Choosing the most cost-effective service for the research question. | Avoids paying for unneeded throughput or features. |
Key Value Bundles and Cost-Saving Strategies
- {"title":"Understanding Value Bundles","description":"Value bundles are pre-packaged service offerings that combine multiple genomics services at a discounted rate compared to ordering them individually. These are designed to streamline common research workflows and offer predictable costs."}
- {"title":"Common Genomics Service Categories","description":"Genomics core facilities typically offer a range of services, including library preparation, sequencing (various platforms like Illumina, PacBio, Oxford Nanopore), bioinformatics analysis, and data storage/management."}
- {"title":"Sequencing-Centric Bundles","description":"These often include library preparation tailored for a specific sequencing platform and a set amount of sequencing read depth. Examples include whole-genome sequencing bundles, RNA-Seq bundles, or ChIP-Seq bundles."}
- {"title":"Targeted Sequencing Bundles","description":"Focus on specific genes or regions of interest, often involving custom probe design and enrichment followed by sequencing. These are cost-effective for hypothesis-driven research."}
- {"title":"Single-Cell Genomics Bundles","description":"Combine cell isolation, library preparation for single-cell RNA sequencing (scRNA-seq) or other single-cell assays, and initial data processing."}
- {"title":"Bioinformatics Analysis Bundles","description":"These bundles can include primary data processing, quality control, alignment, variant calling, differential expression analysis, and sometimes more advanced statistical modeling. Purchasing analysis as a bundle can be significantly cheaper than hiring dedicated bioinformaticians."}
- {"title":"Integrated Project Bundles","description":"Some facilities offer comprehensive bundles that cover the entire project lifecycle, from experimental design consultation and sample QC to library prep, sequencing, and extensive bioinformatics analysis, often with dedicated project management."}
- {"title":"Volume Discounts","description":"Many facilities offer tiered pricing based on the volume of samples or services ordered. Committing to larger projects or regular sample submission can unlock significant cost savings."}
- {"title":"Shared Resource Models","description":"Core facilities themselves are a form of cost-saving by pooling resources. Collaborating with other labs to submit samples collectively can often meet volume discount thresholds."}
- {"title":"In-House vs. Core Facility Costs","description":"Before engaging a core, researchers should perform a realistic cost-benefit analysis of conducting experiments in-house versus using the core. The 'hidden costs' of in-house work (equipment maintenance, reagents, technician time, training) are often underestimated."}
- {"title":"Optimizing Sample Input","description":"Working with core facility staff to ensure optimal sample quality and quantity can prevent failed experiments and wasted reagents/sequencing capacity."}
- {"title":"Data Management and Storage","description":"Understand the data storage policies of the core. Long-term storage can incur costs, so plan for data archival and retrieval strategies proactively."}
- {"title":"Negotiating Service Agreements","description":"For large or recurring projects, there may be room for negotiation on pricing or service inclusions. Building a good relationship with the core facility manager is beneficial."}
- {"title":"Leveraging Facility Expertise","description":"Don't just see the core as a 'service provider.' Their expertise in experimental design, troubleshooting, and data interpretation can prevent costly errors and lead to more impactful results, which is a significant part of the 'value'."}
- {"title":"Prioritizing Essential Services","description":"Carefully evaluate which services are truly necessary for your research question. Avoid unnecessary add-ons or higher-throughput options if a more basic service will suffice."}
Verified Providers In Equatorial Guinea
In Equatorial Guinea, ensuring access to reliable healthcare is paramount. When seeking medical services, it's crucial to identify and engage with 'Verified Providers.' These are healthcare professionals and institutions that have undergone rigorous vetting processes, demonstrating adherence to high standards of quality, safety, and ethical practice. Franance Health stands out as a leading entity in this space, offering a robust credentialing system that assures patients of the expertise and legitimacy of the providers they work with. Their commitment to verification is not just a formality; it's a cornerstone of their mission to elevate healthcare accessibility and quality in the region.
| Provider Type | Franance Health Verification Indicators | Benefits for Patients |
|---|---|---|
| Hospitals & Clinics | Accreditation status, adherence to hygiene standards, patient safety records, availability of specialized equipment. | Access to modern facilities, reduced risk of hospital-acquired infections, assurance of appropriate equipment for diagnosis and treatment. |
| Specialist Physicians | Medical board certifications, postgraduate training verification, peer reviews, professional membership in recognized bodies. | Confidence in receiving expert care for specific medical conditions, assurance of up-to-date knowledge and skills. |
| General Practitioners | Valid medical license, continuous professional development (CPD) records, patient feedback mechanisms. | Reliable primary care services, continuity of care, assurance of up-to-date medical knowledge. |
| Diagnostic Laboratories | Quality control certifications (e.g., ISO standards), proficiency testing results, qualified technical staff. | Accurate and reliable diagnostic results, ensuring correct treatment plans. |
Why Franance Health Credentials Matter:
- Rigorous Vetting Process: Franance Health employs a comprehensive evaluation of medical professionals and facilities. This includes verifying academic qualifications, professional licenses, practical experience, and adherence to international best practices.
- Commitment to Quality and Safety: Credentials issued by Franance Health signify that providers meet stringent quality control measures and safety protocols, minimizing risks and maximizing patient well-being.
- Enhanced Patient Trust: By providing a clear and reliable indicator of a provider's legitimacy, Franance Health empowers patients to make informed decisions and fosters a greater sense of trust in the healthcare system.
- Ethical Practice Assurance: The verification process often includes checks for adherence to ethical guidelines and professional conduct, ensuring that patients are treated with respect and integrity.
- Access to Specialized Expertise: Franance Health's network includes a diverse range of specialists. Their verification process ensures that these specialists possess the necessary qualifications and experience to handle complex medical needs.
- International Recognition: Franance Health's standards are often aligned with international healthcare benchmarks, making it easier for patients and healthcare professionals to understand the level of care provided.
Scope Of Work For Genomics Core Facilities
This Scope of Work outlines the technical deliverables and standard specifications for the Genomics Core Facilities, encompassing a range of services essential for cutting-edge genomic research. The core facility will provide access to advanced instrumentation, expert technical support, and comprehensive data analysis pipelines to facilitate projects from sample preparation through to interpretable biological insights.
| Service Category | Technical Deliverables | Standard Specifications | Associated Technologies |
|---|---|---|---|
| NGS Library Preparation | Quantified, quality-controlled DNA/RNA libraries suitable for downstream sequencing. | Library insert size distribution within specified range (e.g., 300-600 bp for paired-end). DNA/RNA input requirements met (e.g., >10 ng for DNA, >100 ng for RNA). Adapter ligation efficiency >90%. QC metrics including Qubit, Bioanalyzer/TapeStation, and qPCR yield. | Illumina TruSeq, NEBNext, SMART-Seq2, Qiagen kits. |
| NGS Data Generation | Raw sequencing data in FASTQ format, quality scores, and sequencing metrics report. | Targeted read depth/coverage (e.g., >30x for whole-genome sequencing, >100x for exome sequencing, >50 million reads for RNA-Seq). Base quality > Q30 for >80% of bases. Paired-end reads with specified insert sizes. Run times adhering to project timelines. | Illumina NovaSeq, MiSeq, NextSeq platforms. PacBio Sequel, Oxford Nanopore PromethION. |
| Single-Cell Genomics | Demultiplexed, quality-filtered single-cell RNA-seq (scRNA-seq) data (FASTQ or BAM), including cell barcodes and UMI information. | Targeted number of cells per sample (e.g., 1,000-10,000 cells). Minimum UMIs/gene per cell. High cell viability (>90%). Data quality metrics including ambient RNA levels and doublet detection. | 10x Genomics Chromium, BD Rhapsody, Fluidigm C1. |
| Genotyping and SNP Analysis | Variant Call Format (VCF) files containing identified SNPs and indels. Genotype calls with high confidence scores. | High call rate (>98%). Genotype accuracy >99% as assessed by known controls. Minimum variant quality score thresholds. | Illumina iSeq, SNP arrays, ddRAD-seq. |
| Bioinformatics and Data Analysis | Processed and analyzed genomic data, including alignment, variant calling, gene expression quantification, differential expression analysis, pathway analysis, and report generation. | Standardized analysis pipelines with documented parameters. reproducible results. Quality control reports at each stage of analysis. Data deliverables in common formats (e.g., BAM, VCF, counts matrices, tables). | STAR, HISAT2, BWA, GATK, DESeq2, edgeR, Seurat, Python/R scripting. |
Key Genomics Services Offered
- Next-Generation Sequencing (NGS) Library Preparation
- NGS Data Generation (various platforms and read lengths)
- Single-Cell Genomics
- Genotyping and SNP analysis
- Gene Expression Profiling (RNA-Seq, microarrays)
- Epigenomics (ChIP-Seq, ATAC-Seq, Bisulfite Sequencing)
- Metagenomics and Microbiome Analysis
- Long-Read Sequencing
- Bioinformatics and Data Analysis Support
- Consultation and Experimental Design
Service Level Agreement For Genomics Core Facilities
This Service Level Agreement (SLA) outlines the response times and uptime guarantees for the Genomics Core Facilities. It is designed to ensure timely and reliable access to our services and equipment for our users. This SLA applies to all services and equipment managed by the Genomics Core Facilities. Any exceptions or modifications must be documented and agreed upon in writing by both parties.
| Service Category | Response Time Target (Business Hours) | Uptime Guarantee (%) |
|---|---|---|
| Sequencing Platforms (e.g., Illumina NovaSeq, PacBio Sequel II) | 4 Business Hours (for critical instrument failures/outages) | 95% |
| Next-Generation Sequencing Library Preparation | 8 Business Hours (for initial troubleshooting) | 98% |
| Bioinformatics Support (data analysis, troubleshooting) | 1 Business Day (for initial response and triage) | N/A (Support is provided as a service, not an uptime guarantee) |
| Sample Processing (e.g., DNA/RNA extraction, QC) | 1 Business Day (for initial assessment) | 98% |
| Microscopy and Imaging Equipment | 8 Business Hours (for critical instrument issues) | 95% |
| General Inquiries and Consultation | 2 Business Days (for initial response) | N/A |
Key Performance Indicators (KPIs)
- Response Time: The maximum time allowed for the Genomics Core Facilities to acknowledge and begin addressing a user-reported issue or service request.
- Uptime Guarantee: The percentage of time that critical services and equipment are expected to be available and operational.
In-Depth Guidance
Frequently Asked Questions
Phase 02: Execution
Ready when you are
Let's scope your Genomics Core Facilities in Equatorial Guinea project in Equatorial Guinea.
OEM Approved
54Regions
Scaling healthcare logistics and technical systems across the entire continent.